Nahdi Medical Company
4164.SRSAUHealthcare● Active
$95.40
$-0.10(-0.10%)
Market Cap$12.4B
P/E Ratio—
52W High$132.1
52W Low$91
Nahdi Medical Company (4164.SR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 4164.SR · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $10.21B | $9.45B | $8.71B | $8.62B | $8.07B |
| Cost of Revenue | $6.41B | $5.91B | $5.28B | $5.10B | $4.76B |
| Gross Profit | $3.81B | $3.53B | $3.44B | $3.52B | $3.30B |
| Gross Margin %(computed) | 37.26% | 37.40% | 39.43% | 40.86% | 40.97% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.06B | $0.06B | $0.08B | $0.07B | $0.05B |
| Total Operating Expenses | $2.88B | $2.66B | $2.47B | $2.53B | $2.43B |
| Operating Income | $0.91B | $0.87B | $0.96B | $1.00B | $0.92B |
| Operating Margin %(computed) | 8.89% | 9.24% | 11.03% | 11.64% | 11.40% |
| Interest Income | $0.05B | $0.05B | $0.06B | $0.01B | $0.00B |
| Interest Expense | $0.14B | $0.12B | $0.08B | $0.08B | $0.08B |
| Income Before Tax | $0.85B | $0.83B | $0.94B | $0.94B | $0.86B |
| Income Tax Expense | $0.02B | $0.01B | $0.05B | $0.05B | $0.04B |
| Net Income | $0.83B | $0.82B | $0.89B | $0.89B | $0.81B |
| Net Margin %(computed) | 8.13% | 8.69% | 10.24% | 10.30% | 10.07% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $6.39 | $6.31 | $6.87 | $6.83 | $6.25 |
| Wtd Avg Shares | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B |
| EBITDA | $1.69B | $1.61B | $1.64B | $1.59B | $1.51B |
| EBITDA Margin %(computed) | 16.54% | 17.06% | 18.86% | 18.40% | 18.68% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Nahdi Medical Company data
About Nahdi Medical Company (4164.SR) Income Statement
Nahdi Medical Company (4164.SR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, 4164.SR reported revenue of $10.21B, gross profit of $3.81B (gross margin 37.26%), and net income of $0.83B — a net profit margin of 8.13%.
Frequently asked questions
4164.SR · 4 questionsNahdi Medical Company (4164.SR) reported revenue of $10.21B for 2025, up 8.1% year-over-year.
4164.SR revenue4164.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15